Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 31

Trial Status

Completed2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT01075321Phase 1/2Completed
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+16 more
StudychairStart date: 2011-01-10
NCT00432458Phase 3Completed
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Principalinvestigator

Research Network

Collaboration Network

11 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Thomas E. Witzig, M.D.

Mayo Clinic

Very Similar
1 trials

Shared therapeutic areas:

Adult Nasal Type Extranodal NK/T-cell LymphomaLymphoma, Large-Cell, AnaplasticAngioimmunoblastic T-cell Lymphoma+16 more

Worked with same sponsors:

Mayo Clinic
Collaborated on 1 trial
Similarity Score194%

Thomas E. Witzig, MD

Mayo Clinic

Moderately Similar
12 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell NeoplasmLymphoma, Large-Cell, AnaplasticAngioimmunoblastic T-cell Lymphoma+1 more

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score44%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
12 trials

Shared therapeutic areas:

Recurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular Lymphoma+16 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score28%

Vivek Roy, M.D.

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score14%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Recurrent Mantle Cell LymphomaWaldenstrom Macroglobulinemia
Similarity Score3%

Jun Zhu, MD

Peking University Cancer Hospital & Institute

Related
12 trials

Shared therapeutic areas:

Lymphoma, T-Cell, PeripheralLymphoma, Large-Cell, Anaplastic
Similarity Score3%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Eliot Epner, MD

Penn State Hershey Cancer Institute

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score2%

Maria Delioukina, MD

City of Hope National Medical Center, USA

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01075321Phase 1/2StudyChair

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+16 more
Completed
NCT00432458Phase 3PrincipalInvestigator

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
Completed

All 2 trials loaded